Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study by Dell'Osso B, Arici C, Dobrea C, Camuri G, Benatti B, Altamura AC

Get full text

Dominance of mutations in epigenetic regulators and a diversity of signaling alterations in blast-phase BCR::ABL1-negative myeloproliferative neoplasms by Gurban, P, Mambet, C, Botezatu, A, Necula, LG, Matei, L, Neagu, AI, Pitica, I, Ataman, M, Tatic, A, Bardas, A, Gaman, MA, Dobrea, C, Dragomir, M, Ghimici, C, Angelescu, S, Barbu, D, Stanca, O, Danila, M, Berbec, N, Colita, A, Vladareanu, AM, Nedeianu, S, Chivu-Economescu, M, Bleotu, C, Coriu, D, Sepulchre, E, Anton, G, Diaconu, CC, Constantinescu, SN